A detailed history of Brevan Howard Capital Management LP transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 17,480 shares of TMDX stock, worth $2.01 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
17,480
Previous 10,351 68.87%
Holding current value
$2.01 Million
Previous $1.39 Million 41.38%
% of portfolio
0.01%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
$103.61 - $132.04 $738,635 - $941,313
7,129 Added 68.87%
17,480 $1.96 Million
Q2 2025

Aug 14, 2025

BUY
$67.67 - $143.04 $700,452 - $1.48 Million
10,351 New
10,351 $1.39 Million
Q4 2024

Feb 14, 2025

BUY
$59.28 - $144.9 $599,557 - $1.47 Million
10,114 New
10,114 $630,000

Others Institutions Holding TMDX

About TransMedics Group, Inc.


  • Ticker TMDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 31,831,400
  • Market Cap $3.66B
  • Description
  • TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...
More about TMDX
Track This Portfolio

Track Brevan Howard Capital Management LP Portfolio

Follow Brevan Howard Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brevan Howard Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Brevan Howard Capital Management LP with notifications on news.